Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 1 |
GO:0005654 | nucleoplasm | 2 | 1 |
GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex | 4 | 1 |
GO:0005849 | mRNA cleavage factor complex | 3 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:0140513 | nuclear protein-containing complex | 2 | 1 |
Related structures:
AlphaFold database: E9ARF9
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006379 | mRNA cleavage | 7 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0016071 | mRNA metabolic process | 6 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 5 | 1 |
GO:0090501 | RNA phosphodiester bond hydrolysis | 6 | 1 |
GO:0098787 | mRNA cleavage involved in mRNA processing | 8 | 1 |
GO:0098789 | pre-mRNA cleavage required for polyadenylation | 9 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 7 |
GO:0003723 | RNA binding | 4 | 7 |
GO:0005488 | binding | 1 | 7 |
GO:0097159 | organic cyclic compound binding | 2 | 7 |
GO:1901363 | heterocyclic compound binding | 2 | 7 |
GO:0003729 | mRNA binding | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 357 | 359 | PF00675 | 0.459 |
CLV_NRD_NRD_1 | 365 | 367 | PF00675 | 0.508 |
CLV_NRD_NRD_1 | 75 | 77 | PF00675 | 0.297 |
CLV_PCSK_KEX2_1 | 400 | 402 | PF00082 | 0.674 |
CLV_PCSK_PC1ET2_1 | 400 | 402 | PF00082 | 0.674 |
CLV_PCSK_SKI1_1 | 134 | 138 | PF00082 | 0.468 |
CLV_PCSK_SKI1_1 | 19 | 23 | PF00082 | 0.292 |
CLV_PCSK_SKI1_1 | 27 | 31 | PF00082 | 0.320 |
CLV_PCSK_SKI1_1 | 397 | 401 | PF00082 | 0.593 |
CLV_PCSK_SKI1_1 | 64 | 68 | PF00082 | 0.269 |
CLV_PCSK_SKI1_1 | 76 | 80 | PF00082 | 0.269 |
CLV_Separin_Metazoa | 355 | 359 | PF03568 | 0.470 |
DEG_APCC_DBOX_1 | 133 | 141 | PF00400 | 0.468 |
DEG_SCF_FBW7_1 | 1 | 8 | PF00400 | 0.575 |
DOC_MAPK_gen_1 | 76 | 82 | PF00069 | 0.469 |
DOC_PP2B_LxvP_1 | 203 | 206 | PF13499 | 0.791 |
DOC_PP4_FxxP_1 | 333 | 336 | PF00568 | 0.654 |
DOC_PP4_MxPP_1 | 264 | 267 | PF00568 | 0.662 |
DOC_PP4_MxPP_1 | 285 | 288 | PF00568 | 0.662 |
DOC_USP7_MATH_1 | 381 | 385 | PF00917 | 0.637 |
DOC_USP7_MATH_1 | 399 | 403 | PF00917 | 0.615 |
DOC_USP7_UBL2_3 | 344 | 348 | PF12436 | 0.610 |
DOC_USP7_UBL2_3 | 359 | 363 | PF12436 | 0.409 |
DOC_USP7_UBL2_3 | 367 | 371 | PF12436 | 0.512 |
DOC_USP7_UBL2_3 | 396 | 400 | PF12436 | 0.613 |
DOC_USP7_UBL2_3 | 404 | 408 | PF12436 | 0.602 |
DOC_WW_Pin1_4 | 1 | 6 | PF00397 | 0.596 |
DOC_WW_Pin1_4 | 123 | 128 | PF00397 | 0.559 |
DOC_WW_Pin1_4 | 148 | 153 | PF00397 | 0.507 |
DOC_WW_Pin1_4 | 179 | 184 | PF00397 | 0.699 |
DOC_WW_Pin1_4 | 198 | 203 | PF00397 | 0.636 |
LIG_Actin_WH2_2 | 14 | 29 | PF00022 | 0.469 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.560 |
LIG_eIF4E_1 | 68 | 74 | PF01652 | 0.469 |
LIG_FHA_1 | 340 | 346 | PF00498 | 0.513 |
LIG_FHA_2 | 33 | 39 | PF00498 | 0.469 |
LIG_FHA_2 | 56 | 62 | PF00498 | 0.476 |
LIG_Integrin_isoDGR_2 | 42 | 44 | PF01839 | 0.269 |
LIG_LIR_Apic_2 | 331 | 336 | PF02991 | 0.540 |
LIG_LIR_Gen_1 | 351 | 361 | PF02991 | 0.474 |
LIG_LIR_Nem_3 | 351 | 357 | PF02991 | 0.478 |
LIG_LIR_Nem_3 | 8 | 13 | PF02991 | 0.385 |
LIG_SH2_STAP1 | 364 | 368 | PF00017 | 0.541 |
LIG_SH2_STAT5 | 13 | 16 | PF00017 | 0.469 |
LIG_SH3_3 | 203 | 209 | PF00018 | 0.647 |
LIG_SH3_3 | 264 | 270 | PF00018 | 0.627 |
LIG_SH3_3 | 84 | 90 | PF00018 | 0.502 |
LIG_TRAF2_2 | 272 | 277 | PF00917 | 0.653 |
LIG_UBA3_1 | 136 | 144 | PF00899 | 0.486 |
LIG_WW_3 | 265 | 269 | PF00397 | 0.623 |
MOD_CK1_1 | 175 | 181 | PF00069 | 0.713 |
MOD_CK1_1 | 384 | 390 | PF00069 | 0.613 |
MOD_CK2_1 | 399 | 405 | PF00069 | 0.595 |
MOD_Cter_Amidation | 74 | 77 | PF01082 | 0.269 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.567 |
MOD_GlcNHglycan | 174 | 177 | PF01048 | 0.645 |
MOD_GlcNHglycan | 184 | 187 | PF01048 | 0.661 |
MOD_GlcNHglycan | 196 | 199 | PF01048 | 0.820 |
MOD_GlcNHglycan | 210 | 213 | PF01048 | 0.578 |
MOD_GlcNHglycan | 320 | 323 | PF01048 | 0.655 |
MOD_GlcNHglycan | 330 | 333 | PF01048 | 0.672 |
MOD_GlcNHglycan | 374 | 377 | PF01048 | 0.559 |
MOD_GlcNHglycan | 382 | 386 | PF01048 | 0.610 |
MOD_GlcNHglycan | 387 | 390 | PF01048 | 0.605 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.575 |
MOD_GSK3_1 | 175 | 182 | PF00069 | 0.801 |
MOD_GSK3_1 | 194 | 201 | PF00069 | 0.738 |
MOD_GSK3_1 | 204 | 211 | PF00069 | 0.697 |
MOD_GSK3_1 | 381 | 388 | PF00069 | 0.679 |
MOD_GSK3_1 | 399 | 406 | PF00069 | 0.510 |
MOD_N-GLC_1 | 227 | 232 | PF02516 | 0.508 |
MOD_N-GLC_1 | 328 | 333 | PF02516 | 0.558 |
MOD_NEK2_1 | 118 | 123 | PF00069 | 0.581 |
MOD_NEK2_1 | 157 | 162 | PF00069 | 0.475 |
MOD_NEK2_1 | 194 | 199 | PF00069 | 0.762 |
MOD_NEK2_2 | 339 | 344 | PF00069 | 0.560 |
MOD_Plk_1 | 17 | 23 | PF00069 | 0.469 |
MOD_Plk_1 | 37 | 43 | PF00069 | 0.383 |
MOD_Plk_2-3 | 55 | 61 | PF00069 | 0.469 |
MOD_Plk_4 | 250 | 256 | PF00069 | 0.675 |
MOD_Plk_4 | 32 | 38 | PF00069 | 0.493 |
MOD_ProDKin_1 | 1 | 7 | PF00069 | 0.585 |
MOD_ProDKin_1 | 123 | 129 | PF00069 | 0.553 |
MOD_ProDKin_1 | 148 | 154 | PF00069 | 0.502 |
MOD_ProDKin_1 | 179 | 185 | PF00069 | 0.699 |
MOD_ProDKin_1 | 198 | 204 | PF00069 | 0.632 |
MOD_SUMO_rev_2 | 360 | 368 | PF00179 | 0.480 |
MOD_SUMO_rev_2 | 388 | 398 | PF00179 | 0.608 |
TRG_DiLeu_BaEn_1 | 132 | 137 | PF01217 | 0.458 |
TRG_DiLeu_BaLyEn_6 | 131 | 136 | PF01217 | 0.459 |
TRG_ENDOCYTIC_2 | 262 | 265 | PF00928 | 0.672 |
TRG_ENDOCYTIC_2 | 68 | 71 | PF00928 | 0.504 |
TRG_NLS_MonoExtC_3 | 399 | 404 | PF00514 | 0.614 |
TRG_NLS_MonoExtN_4 | 397 | 404 | PF00514 | 0.612 |
TRG_Pf-PMV_PEXEL_1 | 134 | 138 | PF00026 | 0.468 |
TRG_Pf-PMV_PEXEL_1 | 366 | 370 | PF00026 | 0.500 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P353 | Leptomonas seymouri | 53% | 100% |
A0A3Q8IE55 | Leishmania donovani | 95% | 100% |
A4HXP8 | Leishmania infantum | 94% | 100% |
E9AI57 | Leishmania braziliensis | 85% | 100% |
Q4QE20 | Leishmania major | 95% | 100% |